StarZero All shows Try the podcast clipper →

Mar 4, 2025 · 30m · the-pitch

#96 A Test of Time

Claire Coder · 12m spoken Josh Muccio · 6m spoken Daniel Gulati · 2m spoken Phil Nadel · 2m spoken James Altucher · 1m spoken Jillian Manus · 1m spoken
0:00 / 0:00
▶ Watch on YouTube →

gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions

This retrospective episode of The Pitch tracks the three-year journey of Aunt Flo founder Claire Coder, examining her initial 2017 boardroom pitch, a broken angel investor commitment, and her startup's resilient growth and pandemic pivot to profitability.

How this conversation actually went

Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Josh holds 28.1% of the talking time here. How this is scored →

Josh as informed peer 4.6 Guest teaching 4.6 Guest disagreement 2.8 Josh pushing back 5.0
05100:0010:0020:0030:001:58–7:32 · Josh as informed peer 4/10 Pitching Aunt Flo and the Workplace Menstruation Problem The investors probe the basic mechanics and necessity of workplace menstruation products. Claire educates them with statistics on unexpected periods and European non-applicator tampon market adoption, correcting initial skepticism.7:32–13:15 · Josh as informed peer 6/10 Debating the B2B Value Proposition and Pricing Phil Nadel and James Altucher heavily challenge Claire on why enterprise clients would pay a premium rather than buying bulk products elsewhere. Claire defends her B2B value proposition, social mission, and branding power firmly.13:16–17:36 · Josh as informed peer 6/10 Investor Scrutiny, Valuation Haggling, and Final Decisions Daniel Gulati and Phil press Claire on low barriers to entry and customer acquisition defensibility. The investors pass one by one due to valuation, margins, and non-applicator product limitations.17:39–23:35 · Josh as informed peer 3/10 Deal Terms and the Vanishing Investor Josh and Claire discuss James Altucher ghosting her post-pitch and her successful follow-on raise with Charles Hudson. The conversation is amicable as Claire shares how she engineered new biodegradable dispensers based on customer feedback.23:36–28:59 · Josh as informed peer 4/10 Surviving COVID-19 with Work Flow and Achieving Profitability Josh questions Claire on losing 90% of revenue during pandemic office closures and whether Aunt Flo ceased being a tampon company. Claire gently corrects him, explaining how pivoting into workplace sanitization PPE fueled profitability.1:58–7:32 · Guest teaching 6/10 Pitching Aunt Flo and the Workplace Menstruation Problem The investors probe the basic mechanics and necessity of workplace menstruation products. Claire educates them with statistics on unexpected periods and European non-applicator tampon market adoption, correcting initial skepticism.7:32–13:15 · Guest teaching 5/10 Debating the B2B Value Proposition and Pricing Phil Nadel and James Altucher heavily challenge Claire on why enterprise clients would pay a premium rather than buying bulk products elsewhere. Claire defends her B2B value proposition, social mission, and branding power firmly.13:16–17:36 · Guest teaching 3/10 Investor Scrutiny, Valuation Haggling, and Final Decisions Daniel Gulati and Phil press Claire on low barriers to entry and customer acquisition defensibility. The investors pass one by one due to valuation, margins, and non-applicator product limitations.17:39–23:35 · Guest teaching 4/10 Deal Terms and the Vanishing Investor Josh and Claire discuss James Altucher ghosting her post-pitch and her successful follow-on raise with Charles Hudson. The conversation is amicable as Claire shares how she engineered new biodegradable dispensers based on customer feedback.23:36–28:59 · Guest teaching 5/10 Surviving COVID-19 with Work Flow and Achieving Profitability Josh questions Claire on losing 90% of revenue during pandemic office closures and whether Aunt Flo ceased being a tampon company. Claire gently corrects him, explaining how pivoting into workplace sanitization PPE fueled profitability.1:58–7:32 · Guest disagreement 3/10 Pitching Aunt Flo and the Workplace Menstruation Problem The investors probe the basic mechanics and necessity of workplace menstruation products. Claire educates them with statistics on unexpected periods and European non-applicator tampon market adoption, correcting initial skepticism.7:32–13:15 · Guest disagreement 4/10 Debating the B2B Value Proposition and Pricing Phil Nadel and James Altucher heavily challenge Claire on why enterprise clients would pay a premium rather than buying bulk products elsewhere. Claire defends her B2B value proposition, social mission, and branding power firmly.13:16–17:36 · Guest disagreement 4/10 Investor Scrutiny, Valuation Haggling, and Final Decisions Daniel Gulati and Phil press Claire on low barriers to entry and customer acquisition defensibility. The investors pass one by one due to valuation, margins, and non-applicator product limitations.17:39–23:35 · Guest disagreement 1/10 Deal Terms and the Vanishing Investor Josh and Claire discuss James Altucher ghosting her post-pitch and her successful follow-on raise with Charles Hudson. The conversation is amicable as Claire shares how she engineered new biodegradable dispensers based on customer feedback.23:36–28:59 · Guest disagreement 2/10 Surviving COVID-19 with Work Flow and Achieving Profitability Josh questions Claire on losing 90% of revenue during pandemic office closures and whether Aunt Flo ceased being a tampon company. Claire gently corrects him, explaining how pivoting into workplace sanitization PPE fueled profitability.1:58–7:32 · Josh pushing back 5/10 Pitching Aunt Flo and the Workplace Menstruation Problem The investors probe the basic mechanics and necessity of workplace menstruation products. Claire educates them with statistics on unexpected periods and European non-applicator tampon market adoption, correcting initial skepticism.7:32–13:15 · Josh pushing back 7/10 Debating the B2B Value Proposition and Pricing Phil Nadel and James Altucher heavily challenge Claire on why enterprise clients would pay a premium rather than buying bulk products elsewhere. Claire defends her B2B value proposition, social mission, and branding power firmly.13:16–17:36 · Josh pushing back 7/10 Investor Scrutiny, Valuation Haggling, and Final Decisions Daniel Gulati and Phil press Claire on low barriers to entry and customer acquisition defensibility. The investors pass one by one due to valuation, margins, and non-applicator product limitations.17:39–23:35 · Josh pushing back 2/10 Deal Terms and the Vanishing Investor Josh and Claire discuss James Altucher ghosting her post-pitch and her successful follow-on raise with Charles Hudson. The conversation is amicable as Claire shares how she engineered new biodegradable dispensers based on customer feedback.23:36–28:59 · Josh pushing back 4/10 Surviving COVID-19 with Work Flow and Achieving Profitability Josh questions Claire on losing 90% of revenue during pandemic office closures and whether Aunt Flo ceased being a tampon company. Claire gently corrects him, explaining how pivoting into workplace sanitization PPE fueled profitability.

speaking balance: gold is Josh, purple is the guest (3 minute bins)

0:00 · Josh 58.7% · guest 41.3%0:00 · Josh 58.7% · guest 41.3%3:00 · Josh 0% · guest 100%3:00 · Josh 0% · guest 100%6:00 · Josh 0% · guest 100%6:00 · Josh 0% · guest 100%9:00 · Josh 0% · guest 100%9:00 · Josh 0% · guest 100%12:00 · Josh 13.4% · guest 86.6%12:00 · Josh 13.4% · guest 86.6%15:00 · Josh 11.1% · guest 88.9%15:00 · Josh 11.1% · guest 88.9%18:00 · Josh 55.1% · guest 44.9%18:00 · Josh 55.1% · guest 44.9%21:00 · Josh 47.7% · guest 52.3%21:00 · Josh 47.7% · guest 52.3%24:00 · Josh 27.9% · guest 72.1%24:00 · Josh 27.9% · guest 72.1%27:00 · Josh 53.8% · guest 46.2%27:00 · Josh 53.8% · guest 46.2%30:00 · Josh 100% · guest 0%30:00 · Josh 100% · guest 0%
Sharpest disagreement ▶ 11:37 Altucher calls branding reasons bullshit in favor of productivity

James bluntly dismisses the branding and PR justification as total bullshit, arguing the sole viable corporate pitch is raw productivity savings.

 Hardest push from Josh ▶ 9:46 Phil presses why Chase would buy from Aunt Flo over Amazon

Phil refuses to accept vague enterprise reasoning, demanding clear justification for why corporate buyers would pay a premium over Amazon or bulk suppliers.

 Biggest teaching moment ▶ 7:07 Claire breaks down European vs US tampon adoption stats

Claire educates the male investor panel on market data, explaining that OB non-applicators hold 86% market share in Europe despite only 6% in the US.

 Josh holds their own ▶ 13:42 Daniel analyzes share of wallet as the true moat

Daniel demonstrates venture expertise by dissecting why client count alone is not a sufficient moat without expanding product lines and share of wallet.
the scores for every segment, with the reasoning behind each
ChapterTopicJosh as informed peerGuest teachingGuest disagreementJosh pushing backWhy
Pitching Aunt Flo and the Workplace Menstruation Problem 4635 The investors probe the basic mechanics and necessity of workplace menstruation products. Claire educates them with statistics on unexpected periods and European non-applicator tampon market adoption, correcting initial skepticism.
Debating the B2B Value Proposition and Pricing 6547 Phil Nadel and James Altucher heavily challenge Claire on why enterprise clients would pay a premium rather than buying bulk products elsewhere. Claire defends her B2B value proposition, social mission, and branding power firmly.
Investor Scrutiny, Valuation Haggling, and Final Decisions 6347 Daniel Gulati and Phil press Claire on low barriers to entry and customer acquisition defensibility. The investors pass one by one due to valuation, margins, and non-applicator product limitations.
Deal Terms and the Vanishing Investor 3412 Josh and Claire discuss James Altucher ghosting her post-pitch and her successful follow-on raise with Charles Hudson. The conversation is amicable as Claire shares how she engineered new biodegradable dispensers based on customer feedback.
Surviving COVID-19 with Work Flow and Achieving Profitability 4524 Josh questions Claire on losing 90% of revenue during pandemic office closures and whether Aunt Flo ceased being a tampon company. Claire gently corrects him, explaining how pivoting into workplace sanitization PPE fueled profitability.

Statements from this episode (19)

Assertion Partly supported
Coder: 86% of women get unexpected periods in public; 64% leave work
“Myself, I've experienced something that 86% of women have as well, and that's getting my period unexpectedly in public, and there are three options to handle that situation. One is just like 64% of women, they leave work or what they're doing immediately.”
Claire Coder Mar 4, 2025 ▶ 2:43
Disclosure
Coder: 70% of Aunt Flow revenue comes from B2B sales
“70% of our company is selling directly to businesses.”
Claire Coder Mar 4, 2025 ▶ 4:58
Assertion Contradicted
Coder: Aunt Flow is the only direct B2B organic cotton tampon supplier
“So Ontflow is actually the only company that works directly with businesses to supply them with 100% organic cotton tampons.”
Claire Coder Mar 4, 2025 ▶ 5:36
Assertion Partly supported
Coder: Non-applicator tampons are 80% of European sales vs 6% in US
“80 or 86% of tampon sales in Europe are non-applicator tampons, while only six percent of purchases for tampons in the United States are non-applicator.”
Claire Coder Mar 4, 2025 ▶ 7:11
Assertion Not checkable as stated
Coder: Aunt Flow generates $5,000 monthly from DTC subscriptions
“5000 dollars a month.”
Claire Coder Mar 4, 2025 ▶ 7:55
Assertion Partly supported
Coder: Aunt Flow tampons are about 12% more expensive than legacy brands
“So we're about 12% more expensive.”
Claire Coder Mar 4, 2025 ▶ 8:45
Disclosure
Coder: Aunt Flow donates 10 products for every 100 enterprise purchases
“So, for every 100 pieces that a business purchases, we donate 10.”
Claire Coder Mar 4, 2025 ▶ 11:31
Disclosure
Coder: Aunt Flow is raising $500,000 at a $5 million cap
“Yeah, so we're raising 500,000 dollars at a five million cap.”
Claire Coder Mar 4, 2025 ▶ 14:46
Disclosure
Gulati: Passing on Aunt Flow as it lacks venture upside
“It's not quite there for me as a venture capital opportunity, so I'm gonna respectfully pass on the opportunity to invest.”
Daniel Gulati Mar 4, 2025 ▶ 15:21
Prediction Not checkable as stated
Nadel: Tampax or o.b. can crush Aunt Flow on price
“I think that that's a better way to go, but then I'm worried about the competition, because a company like Tampax, or if they want the eco-solution OB, can crush her in terms of price.”
Phil Nadel Mar 4, 2025 ▶ 16:38
Assertion Not checkable as stated
Coder: James Altucher ghosted Aunt Flow after offering an investment
“Never heard from him ever after the show.”
Claire Coder Mar 4, 2025 ▶ 18:06
Assertion Not checkable as stated
Muccio: James Altucher ghosted every founder he committed to on The Pitch
“He did that to every founder he committed to on our show, and he also did it to the show.”
Josh Muccio Mar 4, 2025 ▶ 18:33
Assertion Partly supported
Muccio: Aunt Flow raised $1.5M at a $5M valuation
“She ended up raising 1.5 million at the five million dollar valuation she wanted to.”
Josh Muccio Mar 4, 2025 ▶ 19:37
Assertion Not publicly verifiable
Muccio: Charles Hudson invested $250K into Aunt Flow in 2018
“He invested 250 K in AntFlow in 2018.”
Josh Muccio Mar 4, 2025 ▶ 19:48
Assertion Partly supported
Muccio: Aunt Flow landed accounts with Princeton, Google, and Zappos
“Got her tampons into places like Princeton and Penn State. And over the next few years, they also picked up accounts for state office buildings in Ohio and Iowa, and even big tech companies like Zappos and Google.”
Josh Muccio Mar 4, 2025 ▶ 23:04
Assertion Not checkable as stated
Coder: Aunt Flow signed a contract with Twitter for all offices
“Well, in January, we signed a contract with Twitter for all of their offices.”
Claire Coder Mar 4, 2025 ▶ 23:36
Assertion Not checkable as stated
Coder: Aunt Flow revenue dropped to 10-20% at the onset of COVID
“We took a dramatic hit from, you know, 100% revenue to, I want to say, like, 10% to 20% of that.”
Claire Coder Mar 4, 2025 ▶ 24:24
Assertion Not checkable as stated
Coder: Aunt Flow recovered all lost COVID revenue by pivoting to PPE
“100%, and then some.”
Claire Coder Mar 4, 2025 ▶ 26:52
Assertion Not checkable as stated
Muccio: Aunt Flow achieved profitability in 2020 with seven full-time employees
“Claire said that they have seven full-time employees now at the Columbus, Ohio-based startup, and then the last few months, Antflow just became profitable for the first time ever.”
Josh Muccio Mar 4, 2025 ▶ 28:30
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 100 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more